Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

818.93 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
MarketMasterAI’s Top 500 Stocks: April 2024
My MarketMasterAI system has ranked the top 500 stocks to buy in April and the winners look really different than in January. Here's why. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Eli Lilly and Co's Options: A Look at What the Big Money is Thinking
Via Benzinga
3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April
These high-growth biotech stocks are certainly worth considering for investors looking for market-beating returns in the long-term. 
Via InvestorPlace
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
These companies are close to launching new products that could supercharge revenue. 
Via The Motley Fool
Understanding Eli Lilly and Co's Position In Pharmaceuticals Industry Compared To Competitors
Via Benzinga
Eli Lilly and Co Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Via Benzinga
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
Altimmune has a GLP-1 candidate in Phase 2 trials, but the company continues to burn cash and may need a big pharma partner to get its drug to market 
Via MarketBeat
Exposures Product Safety
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
These stocks, a bargain today, are players to hold on to for the long term. 
Via The Motley Fool
Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
Johnson & Johnson's proposed acquisition of Shockwave Medical may be the jolt that JNJ stock needs to break out of a year-long downtrend 
Via MarketBeat
ProfoundBio Discovers The Joys Of Having A Wealthy Owner
Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a... 
Via Benzinga
2 Growth Stocks to Buy Hand Over Fist in April
These healthcare companies' target markets substantially overlap. 
Via The Motley Fool
This 1 Number May Ensure Eli Lilly's Dominance in the Weight Loss Drug Market
Lilly's stock has climbed in the triple digits over the past 12 months. 
Via The Motley Fool
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.
Shares of the clinical-stage biotech have skyrocketed on recent good news. 
Via The Motley Fool
Could This New Development Soon Buoy Eli Lilly and Novo Nordisk Stock?
New findings could lead to more growth from their prized medicines. 
Via The Motley Fool
Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the Stock
Things are going exactly as planned for the biotech giant. 
Via The Motley Fool
Traders Rethink Interest Rate Cuts, Labor Market Heats Up, Oil Prices Quietly Reach 6-Month High: This Week In The Markets
U.S. economy resilient, manufacturing and labor market strong. Fed officials temper rate cut expectations. Apple shifts focus to home robotics. 
Via Benzinga
Topics Economy
Exposures Economy Interest Rates
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
Corporate bonds offer yield opportunities and diversification away from equity investments. Investment-grade bonds are safer but lower yield, while high-yield bonds offer higher returns but from... 
Via Benzinga
Topics Bonds
Exposures Debt Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Spring 2024 Snapshot Of The S&P 500's Market Cap
The first quarter of 2024 has come and gone. Before it did, the S&P 500 clocked a new record high of 5,254.35. 
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Growth Stocks with Even Greater Potential Than the Magnificent 7
Here are three Magnificent 7 contenders growth investors shouldn't be sleeping on right now, given their long-term potential. 
Via InvestorPlace
7 A-Rated Stocks to Buy in April
These A-rated stocks to buy for April will help you forget about the pain of tax season. Instead, enjoy the profits from these top stocks. 
Via InvestorPlace
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
Viking shares have soared recently on optimism about its program. 
Via The Motley Fool
Why Eli Lilly Stock Topped the Market Today
One analyst following the company believes it could grow its revenue meaningfully this year. 
Via The Motley Fool
The 3 Best Healthcare Stocks to Buy in April 2024
The healthcare industry is not going to stop growing anytime soon. These are the best healthcare stocks to buy in April. 
Via InvestorPlace
Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy
Eli Lilly's stock skyrockets but now trading sideways as demand for weight-loss drugs outpaces supply. Availability issues lead to FDA shortages. 
Via Benzinga
Exposures Product Safety
Novo Nordisk's Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In China
Novo Nordisk warns of Ozempic starter kit scarcity in Germany amid ongoing supply challenges in Europe. Restrictions on off-label use emphasized, with intermittent shortages expected in 2024.... 
Via Benzinga
Exposures Product Safety
Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
Viking Therapeutics is preparing to be the next entry into the GLP-1 Market, and VKTX stock is soaring as analysts start to bid the stock higher 
Via MarketBeat
Exposures Product Safety
Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras
Costco's new weight loss initiative, in partnership with Sesame, a healthcare marketplace, will offer members a three-month clinical consultation and other services for $179. 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.